» Articles » PMID: 27630571

Presynaptic Release-Regulating MGlu1 Receptors in Central Nervous System

Overview
Journal Front Pharmacol
Date 2016 Sep 16
PMID 27630571
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Group I metabotropic glutamate (mGlu) receptors consists of mGlu1 and mGlu5 receptor subtypes. These receptors are widely distributed in the central nervous system (CNS), where they preferentially mediate facilitatory signaling in neurones and glial cells, mainly by favoring phospholipase (PLC) translocation. Based on the literature so far available, group I Metabotropic glutamate receptors (mGluRs) are preferentially expressed at the postsynaptic side of chemical synapsis, where they participate in the progression of the chemical stimulus. Studies, however, have shown the presence of these receptors also at the presynaptic level, where they exert several functions, including the modulation of transmitter exocytosis. Presynaptic Group I mGluRs can be both autoreceptors regulating release of glutamate and heteroreceptors regulating the release of various transmitters, including GABA, dopamine, noradrenaline, and acetylcholine. While the existence of presynaptic release-regulating mGlu5 receptors is largely recognized, the possibility that mGlu1 receptors also are present at this level has been a matter of discussion for a long time. A large body of evidence published in the last decade, however, supports this notion. This review aims at revisiting the data from in vitro studies concerning the existence and the role of release-regulating mGlu1 receptors presynaptically located in nerve terminals isolated from selected regions of the CNS. The functional interaction linking mGlu5 and mGlu1 receptor subtypes at nerve terminals and their relative contributions as modulators of central transmission will also be discussed. We apologize in advance for omission in our coverage of the existing literature.

Citing Articles

Asymmetric dysregulation of glutamate dynamics across the synaptic cleft in a mouse model of Alzheimer's disease.

Brymer K, Hurley E, Barron J, Mukherjee B, Barnes J, Nafar F Acta Neuropathol Commun. 2023; 11(1):27.

PMID: 36788598 PMC: 9926626. DOI: 10.1186/s40478-023-01524-x.


Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19.

Li L, Wang X, Guo X, Li Y, Song Q, Li A Front Pharmacol. 2022; 13:1013428.

PMID: 36210820 PMC: 9540507. DOI: 10.3389/fphar.2022.1013428.


Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?.

Budgett R, Bakker G, Sergeev E, Bennett K, Bradley S Front Pharmacol. 2022; 13:893422.

PMID: 35645791 PMC: 9130574. DOI: 10.3389/fphar.2022.893422.


Synaptosomes and Metamodulation of Receptors.

Pittaluga A, Marchi M Methods Mol Biol. 2022; 2417:99-111.

PMID: 35099794 DOI: 10.1007/978-1-0716-1916-2_8.


Chronic lithium treatment alters the excitatory/ inhibitory balance of synaptic networks and reduces mGluR5-PKC signalling in mouse cortical neurons.

Khayachi A, Ase A, Liao C, Kamesh A, Kuhlmann N, Schorova L J Psychiatry Neurosci. 2021; 46(3):E402-E414.

PMID: 34077150 PMC: 8327978. DOI: 10.1503/jpn.200185.


References
1.
Vazquez E, Herrero I, Miras-Portugal M, Sanchez-Prieto J . Developmental change from inhibition to facilitation in the presynaptic control of glutamate exocytosis by metabotropic glutamate receptors. Neuroscience. 1995; 68(1):117-24. DOI: 10.1016/0306-4522(95)00121-x. View

2.
Marchi M, Grilli M, Pittaluga A . Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals. Front Pharmacol. 2015; 6:89. PMC: 4413670. DOI: 10.3389/fphar.2015.00089. View

3.
Marchi M, Grilli M . Presynaptic nicotinic receptors modulating neurotransmitter release in the central nervous system: functional interactions with other coexisting receptors. Prog Neurobiol. 2010; 92(2):105-11. DOI: 10.1016/j.pneurobio.2010.06.004. View

4.
Pittaluga A, Pattarini R, Feligioni M, Raiteri M . N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid, the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition. J Neurochem. 2001; 76(1):139-48. DOI: 10.1046/j.1471-4159.2001.00057.x. View

5.
Milanese M, Zappettini S, Jacchetti E, Bonifacino T, Cervetto C, Usai C . In vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOD1/G93A(+) mouse model of amyotrophic lateral sclerosis. J Neurochem. 2010; 113(2):489-501. DOI: 10.1111/j.1471-4159.2010.06628.x. View